Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

In childhood leukemia, hematopoietic stem cell transplantation (HSCT) is often included in the comprehensive treatment plan when there is a high risk of recurrence, relapse/refractory disease, or unstable remission. The decision considers disease classification and staging, minimal residual disease
24-72h
Response window
Approx. $5,000
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
Allogeneic hematopoietic stem cell transplantation requires suitable donor cells as a prerequisite, which can be fully matched, unrelated donor, haploidentical, or umbilical cord blood, etc. Usually, preconditioning chemotherapy/radiotherapy is performed first to clear the lesions and create conditions for transplantation, and then the collected stem cells are returned intravenously; during this period, infection control and immunosuppressive drugs are used to reduce graft-versus-host disease. Postoperative focus is on monitoring blood counts, infection indicators, and organ function, with the goal of achieving hematopoietic reconstitution and maintaining disease control. The above is general health information, not medical advice; the specifics are subject to specialist assessment and hospital protocols.
Allogeneic hematopoietic stem cell transplantation requires suitable donor cells as a prerequisite, which can be fully matched, unrelated donor, haploidentical, or umbilical cord blood, etc. Usually, preconditioning chemotherapy/radiotherapy is performed first to clear the lesions and create conditions for transplantation, and then the collected stem cells are returned intravenously; during this period, infection control and immunosuppressive drugs are used to reduce graft-versus-host disease. Postoperative focus is on monitoring blood counts, infection indicators, and organ function, with the goal of achieving hematopoietic reconstitution and maintaining disease control. The above is general health information, not medical advice; the specifics are subject to specialist assessment and hospital protocols.

Considering preoperative evaluation, hospitalization, and postoperative follow-up, it is recommended to stay in China for approximately 8–14 weeks; individual differences are large, subject to the actual schedule and assessment.

Tell us about your Pediatric Leukemia case and we will help match you with the right hospital, specialist, and travel pathway.